MedtecSUMMIT - Congress & Partnering
23 - 25 May 2023
at MedtecLIVE with T4M, NürnbergMesse in Nürnberg
The international congress MedtecSUMMIT together with MedtecLIVE with T4M is the place to be for the medical technology industry. The program contains practice-relevant and scientific contributions on the trend topics: digitalization, artificial intelligence, robotics as well as sustainability and regulation. Take advantage of the wide range of lectures, panel discussions, networking meetings and help shape the future of healthcare.
You would like to participate in MedtecSUMMIT? Here are your options:
Attend MedtecSUMMIT & MedtecLIVE with T4M
MedtecSUMMIT will take place during MedtecLIVE with T4M on the Main as well as Innovation Stage and is included in your MedtecLIVE with T4M ticket!
Attend our PARTNERING Event
Don’t forget to register for our PARTNERING-Event which will also take place from May 23 to May 25, 2023!
MedtecSUMMIT SPONSORING
Would you like to sponsor the MedtecSUMMIT?
Click here for further information or contact us via med@medtech-pharma.de
EXHIBITOR at MedtecLIVE with T4M
Don’t forget to visit MedtecLIVE with T4M and be a part of the exhibition!
Do you want to know more about the different sessions? Then have a look at the Session Abstracts:
Tuesday, 23 May 2023
Main Stage
The implementation of the MDR is still the focus of the industry: Central elements such as EUDAMED are not yet provided, the number and availability of the notified bodies is limited. There are considerable uncertainties regarding the data required for the clinical evaluation and its collection, especially when it comes to so-called legacy or orphan devices. In this session, recognized experts provide information on the current regulations. In this session, recognized experts provide information on the current regulations and illustrate how to master the manifold challenges.
10:00 - 10:10 Welcome, Programm and Activities - Dr. Jörg Traub (Forum MedTech Pharma e.V.)
10:10 - 10:30 Update from the Medtech Society & Data - Julia Steckeler (Medical Mountains GmbH)
10:30 - 10:40 The Gouvernment's View - Ortwin Schulte (Bundesministerium für Gesundheit)
10:40 - 10:50 The Notified Body's View - Dr. Royth van Hahn (TÜV SÜD Product Service GmbH)
10:50 - 11:00 The Industry's View - Ralf Klein (Radimed GmbH)
11:00 - 11:10 The International View - Sinead Keogh (Ibec)
11:10 - 11:20 The Health Care Provider's View - Prof. Dr. Thomas A. Schildhauer (BG Universitätsklinikum Bergmannsheil Bochum)
11:20 - 11:50 Panel Discussion with Speakers
11:50 - 12:00 Wrap Up
Moderation: Julia Steckeler (Medical Mountains GmbH) und Dr. Frank Miermeister (Forum MedTech Pharma e.V.)
The corona pandemic, the delivery of products from various countries and the attack of Russia on Ukraine brought new challenges into the supplier market. The availability of products is not guaranteed, the prices change in raw material and also processes, management, and energy. This requires new solutions and management of the supply chain. To ensure the production in time with the highest needed quality requires a regional concept with global partnerships. A review of the past years and an outlook how to manage production and operation without compromises in quality will be discussed.
12:30 - 12:35 Setting the Scene - Dr. Jörg Traub (Forum MedTech Pharma e.V.)
12:35 - 13:20 Supply Chain - From Crisis Management to Second Sourcing - tba
13:20 - 14:00 Panel Discussion - Dr. Matthias Schier (SASSE Elektronik GmbH), Christian Soehner (FOBA Laser Marking + Engraving), tba
Moderation: Dr. Jörg Traub (Forum MedTech Pharma e.V.)
Wednesday, 24 May 2023
Main Stage
Augmented Reality was introduced a few decades ago as a promising technology to overlay the view of the real world with virtual, computer rendered objects. After almost three decades of research and development, applications in medicine are established and more and more solutions find its way into clinical support - training and further education as well as general guidance with work processes. The clinical perspective will be the focus of this session and the technology of localization, estimation of the pose, the rendering of 3D scenes and general computer vision technology applying also artificial intelligence will be presented and discussed. What is already used in surgery, and what is the potential for telemedicine? The session will provide insights.
10:00 - 10:05 Welcome - tba
10:05 - 10:20 AR in Medicie - History, Science & Vision - Prof. Dr. Nassir Navab (Technische Universität München)
10:20 - 10:35 AR/VR in Surgery - Nissan Elimelech (Augmedics)
10:35 - 10:50 AR/VR in Education & Training - Petra Dahm (StellDirVor GmbH)
10:50 - 11:05 Real Training and Education - tba
11:05 - 11:20 tba
11:20 - 12:00 Panel Discussion
Moderation: Prof. Dr. Thomas A. Schildhauer (BG Universitätsklinikum Bergmannsheil Bochum)
Digitalization is changing the way medicine is applied. Evidence-based medicine is replacing eminence-based medicine. However, the introduction of data-driven solutions and digital tools requires change management to be successful in diagnosis and therapy. What is required to support the success of digital tools for better outcome? What are the roadblocks in current procedures? Who needs to lead the change? With digital health solutions, electronic patient files and patient platforms, we have technical solutions that are still waiting for their broad acceptance and everyday use. It is time to recognize that our current interpretation of data processing puts more people and patients at risk than it protects.
12:30 - 12:45 Digitalization in Surgery - Overview - Prof. Dr. Dirk Wilhelm (Klinikum Rechts der Isar der Technischen Universität München)
12:45 - 13:00 Cybersecurity - Safety in Digital Healtha and Medical Products - tba
13:00 - 14:00 Panel: What is needed that digitalization is integrated in everyday clinical routine - Prof. Dr. Thomas A. Schildhauer (BG Universitätsklinikum Bergmannsheil Bochum), tba
Moderation: Prof. Dr. Dirk Wilhelm (Klinikum Rechts der Isar der Technischen Universität München)
Up to now, clinical robotics with all its advantages and disadvantages has mostly been viewed as an isolated topic. One of the most frequently mentioned disadvantages is the cost-intensive technology and the lack of financing options, especially through reimbursement. Which possible reimbursement, financing models and paths would be conceivable if clinical robotics were not viewed as a stand-alone topic, but rather as an integral part of quality assurance in patient care in the long term? Ideas, possibilities and requirements will be discussed in this session using the German healthcare market as an example.
Innovation Stage
The availability of sensors and platforms raises the possibilities of diagnostics and prevention to a whole new level. Artificial intelligence is an essential part of this in order to use the data volumes generated by various sensors. While the technologies such as sensors and algorithms are widely available, the path to their use in daily routine poses some challenges not only in terms of regulation but also in terms of reimbursement. The session will provide an overview of sensor-based diagnostics technology, the legal framework in the EU and the US, use cases for digital diagnostics, and user needs and perspectives.
10:00-10:05 Setting the Scene - Dr. Narges Ahmidi (Fraunhofer Institute for Congnitive Systems IKS)
10:05-10:20 AI and Smart Sensors in Healthcare and Research - Dr. Christian Münzenmayer (Fraunhofer Institute for Integrated Circuits IIS)
10:30-10:40 Use case: Digital Health Prevention by Breath & Saliva Analysis - Dr.-Ing. Ulrich Jerichow ( VitaScale GmbH)
10:40-10:50 Use Case: Voice as digital biomarker - Dagmar Schuller (audEERING GmbH)
10:50-11:00 Regulatory framework of AI in medicine - Prof Dr. Martin Haimerl (Hochschule Furtwangen)
11:00-11:10 Pathways for reimbursement in digital diagnostics - Stefan Bartosch (DMAC)
11:10-12:00 Panel Discussion: What are we good in, where are needs, how can we create combinations that scale?
Moderation: Dr. Narges Ahmidi (Fraunhofer Institute for Congnitive Systems IKS)
The European Health Data Space has been presented and will become a reality in the coming years. In addition to the regulation for the use of data for health care, the so-called primary use, the data room also envisages use for science and industry, the so-called secondary use. How will this data room be implemented? How can it be accessed? Can "real world" evidence data be accessed for research, development and market monitoring, which is also required in the context of regulation? The session will provide an update on the national and EU framework, show examples of implementation and highlight the challenges in implementation.
14:30-14:35 Setting the Scene: Why do we need a health data ecosystem? - Dr. Georg Münzenrieder (Bayerisches Staatsministerium für Gesundheit und Pflege)
14:35-14:45 Need for Health Data in Industry: Cross Cluster Study - Dr. Jens Wiehler (BioM Biotech Cluster Development GmbH)
14:45-14:55 Patient View on Health Data - Oliver Merx (ONCARE GMBH)
14:55-15:05 European Health Data Space - Magda Krakowiak (EIT Health)
15:05-15:15 Interoperability - The Essence for Health Data & Exchange - Batsenko Dmytro (ZEISS Digital Innovation)
15:15-15:25 TEAM-X - A Gaia-X Data Ecosystem in the Health Domain - Christian Weigand (Fraunhofer IIS)
15:25-15:35 tba
15:35-16:30 Panel Discussion: How to achieve an easy accessible and all time available health data space?
Moderation: Dr. Georg Münzenrieder (Bayerisches Staatsministerium für Gesundheit und Pflege)
Thursday, 25 May 2023
Main Stage
The supply chain in medical technology is responsible for over 70% of the emissions of the healthcare sector. In Germany, that means 26 million t CO2 equivalents, which correspond to 3.9% of the total emissions in Germany. At the same time, we have a resource problem: fossil resources are becoming increasingly scarce and global crisis like chaos in the Suez Canal, pandemics and wars are paralyzing supply chains. This leads to a deterioration in health care due to shortages in supply and increased risks of global supply chains. This session will discuss questions like: How can the medical supply chain become more resilient? How can this sector close loops and strive for a circular economy to overcome those crises? How can we identify the waste of resources in the process chain?
10:00 - 10:05 Welcome - Stefanie Brauer (Forum MedTech Pharma e.V.)
10:05 - 10:20 Insights from the Clinic - Dr. Irena Schwarzer (LMU Klinikum)
10:20 - 10:30 Insights from Procurement - Christoph Pelizaeus (P.E.G. Einkaufs- und Betriebsgenossenschaft eG)
10:30 - 10:40 Insights from SMEs - Dr. Stefanie Dukorn (numares AG)
10:40 - 10:50 Insights from Big Corporates - Patricia Gehrlein (Siemens Healthineers),
10:50 - 11:00 Insights from Science - Dr. Andreas Hamper (Fraunhofer IIS)
11:00 - 12:00 Podium Discussion
Moderation: Stefanie Brauer (Forum MedTech Pharma e.V.)
Science transfers money into knowledge – industry transfers knowledge into money. In high-tech societies that encourage innovation, this is a closed loop that allows for leadership in both high technology and business. In the panel discussion, highlights of transfer projects as well as the transfer poster exhibition will be presented. Renowned experts from science, industry, and politics will discuss great examples, current highlights, the infrastructure and how this healthcare ecosystem will be preserved for us.
12:15 - 12:45 Translation - Overview and Best Practice: Innovation and Translation Landscape in Bavaria - Dr. Tanja Jovanovic (Bayern Innovativ GmbH)
12:45 - 14:00 Podium Discussion with Prof. Dr. Joachim Hornegger (Friedrich-Alexander-Universität Erlangen-Nürnberg), Dr. Peter Schardt (Siemens Healthcare GmbH), Roland Weigert (Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie), Prof. Dr. Georg Duda (Julius Wolff Institute , Berlin Insitute of Health), Dr. Stefanie Demirci (Institut für Innovation und Technik der VDI/VDE Innovation + Technik GmbH)
Moderation: Dr. Jörg Traub (Forum MedTech Pharma e.V.)
Reconstructions in orthopedics or in general in surgery are a common procedure, and implants are frequently used. With new materials, the acceptance of individual implants can be created not only for rigid bone implants, but also biological structures that allow regeneration to take place. In the session, new carrier structures and new procedures for individual bone and cartilage constructions will be presented, the technical state of the art and the vision of 3D printed and cultured absorbable implants up to the potential in organs will be presented and discussed.
Innovation Stage
Intelligent sensors and implants present unprecedented opportunities for effective disease prevention and detection, real-time monitoring of health data and chronic diseases, patient-tailored treatment, and minimally invasive management of diseases.
This session addresses current technological advancements and potential benefits in managing chronic conditions and diseases such as cancer, cardiovascular diseases, cognitive impairment as well as orthopedic surgery or infectious diseases while reflecting on the potential challenges and limitations of their utilization.
10:00 - 10:20 Safe active implants for medicine - Dr. Agnes Bußmann (Fraunhofer EMFT)
10:20 - 10:40 Accelerating Innovation in Medical Devices with In Silico Medicine - Dr. Visa Suomi (The MathWorks GmbH)
10:40 - 11:00 Ultrasonic procedure for detecting prosthesis loosening - Jan Lützelberger (Hochschule für angewandte Wissenschaften Coburg)
11:00 - 11:20 Active implantation techniques and neural implants - Dr. Oliver Bärtl (CorTec GmbH)
11:20 - 11:40 B-Neo: a new type of smart sensor system for a wide range of applications - Mohammad Kabany (B-Horizon GmbH)
11:40 - 12:00 Discussion
Moderator: tba and Jürgen Frickinger (Forum MedTech Pharma e.V.)
The supply chain in medical technology is responsible for over 70% of the emissions of the healthcare sector. In Germany that means 26 Mio t CO2 equivalents which correspond to 3,9% of the total emissions in Germany. At the same time, we have a resource problem: fossil resources are becoming increasingly scarce and global crisis like chaos in the Suez canal, pandemics and wars are paralyzing supply chains. This leads to a deterioration in health care due to shortages in supply and increased risks of global supply chains. This session will show best practices to questions like: How can the medical supply chain become more resilient? How can this sector close loops and strive for a circular economy to overcome those crises? How can we identify the waste of resources in the process chain?
14:00 - 14:20 Sustainability in MedTech & Health - Moritz Gomm (Zühlke Engineering GmbH)
14:20 - 14:35 Best Practice: CO2 Bewertung der Inhouseprozesse - Andreas Hellmann (Hubert Stüken GmbH & Co. KG)
14:35 - 14:50 Best Practice: Kreisläufe schließen durch Digitalisierung - Meike Lessau (Resourcify GmbH)
14:50 - 15:05 Best Practice: Biokunststoffe für Medizintechnik: Urban Legends & echte Potenziale - Dr.-Ing. Julian Lotz (BIOVOX GmbH)
15:05 - 15:20 Best Practice: Reparieren statt Neukaufen - Georg Wagner (Mides Healthcare Technology GmbH)
15:20 - 15:35 Best Practice: Verpackungen - Dr. Ferdinand Somorowsky (Fraunhofer-Institut für Silicatforschung ISC)
15:35 - 16:00 Q&A
Moderation: Moritz Gomm (Zühlke Engineering GmbH)
Visit MedtecLIVE with T4M and be a part of the exhibition!
MedtecSUMMIT is organized by Bayern Innovativ on behalf of the Bavarian Ministry of Economic Affairs, Regional Development and Energy and supported by Forum MedTech Pharma e.V.
Media partner:
